Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2007-09-25
2007-09-25
Weber, Jon (Department: 1657)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007720, C435S018000
Reexamination Certificate
active
10444633
ABSTRACT:
The present invention provides methods for identifying agents that modulate a level or an activity of a mitochondrial NAD-dependent deacetylase polypeptide, as well as agents identified by the methods. The invention further provides methods of modulating mitochondrial NAD-dependent deacetylase activity in a cell. The invention further provides methods of modulating mitochondrial function by modulating the activity of mitochondrial NAD-dependent deacetylase.
REFERENCES:
patent: 2002/0120008 (2002-08-01), Benzer et al.
patent: 2003/0082668 (2003-05-01), Tamal et al.
patent: WO 01/40506 (2001-06-01), None
patent: WO 02/102981 (2002-12-01), None
patent: WO 03-004621 (2003-01-01), None
patent: WO 03/099210 (2003-12-01), None
patent: WO 2004/065169 (2004-07-01), None
Frye, RA (1999) Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (Sirtuins) metabolize NAD and may have protein ADP-Ribosyltransferase activity. Biochemical and Biophysical Res Comm 260: 273-9.
Product Information: Histone from calf thymus Product No. H4380. Sigma online catalog, www.sigma-aldrich.com, 2006.
Ait-Si-Ali S, Ramirez S, Robin P, Trouche D, and Harel-Bellan A (1998) A rapid and sensitive assay for histone acetyl-transferase activity. Nucleic Acids Research 26: pp. 3869-3870.
Imai S, Armstrong CM, Kaeberlein M, and Guarente L (2000) Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature 403: pp. 795-800.
Product Information: Histone from calf thymus Product No. H4380. Sigma online catalog, www.sigma-aldrich.com.
White DA, Belyaev ND, Turner BM (1999) Preparation of site-specific antibodies to acetylated histones. Methods 19: pp. 417-424.
Landry J et al (May 23, 2000) The silencing protein SIR2 and its homologs are NAD-dependent protein deacetylases. Proc Natl Acad Sci, vol. 7, No. 11, pp. 5807-5811.
Sherman JM et al (Sep. 1999) The conserved core of a human SIR2 homologue functions in yeast silencing. Mol Biol Cell, vol. 10, pp. 3045-3059.
Moazed D (published online Mar. 7, 2001) Enzymatic activities of Sir2 and chromatin silencing. Curr Opin Cell Biol, vol. 13, pp. 232-238.
Haigis MC et al (Sep. 8, 2006) SIRT4 inhibits glutamate dehydrogenase and opposes the effects of calorie restriction in pancreatic beta cells. Cell, vol. 126, pp. 941-954.
Yang et al. (2000)Genomics69:355-369.
Frye (2000)Biochem. Biophys. Res. Comm.273:793-798.
GenBank Accession Nos. NM—012239 and AF083109.
Frye, Roy A., “Characterization of five human cDNAs with Homology to the Yeast SIR2 Gene: Sir2-like Proteins (Sirtuins) Metabolize NAD and May Have Protein ADP-Ribosyltransferase Activity”, Biochemical and Biophysical Research Communications, vol. 260, No. 1, (1999), pp. 273-279.
Grozinger et al., “Identification of a Class of Small Molecule Inhibitors of the Sirtuin Family of NAD-dependent Deacetylases by Phenotypic Screening”, The Journal of Biological Chemistry, vol. 276, No. 42, (2001), pp. 38837-38843.
Landry et al., “Role of NAD+ in the Deacetylase Activity of the SIR2-like Proteins”, Biochemical and Biophysical Research Communications, vol. 278, No. 3, (2000), pp. 685-690.
Onyango et al., “SIRT3, a human SIR2 homologue, is an NAD-dependent deacetylase localized to mitochondria”, Proceedings of the National Academy of Sciences, vol. 99, No. 21, (2002), pp. 13653-13658.
Schwer et al., The human silent information regulator (Sir)2 homologue hSIRT3 is a mitochoncrial nicotinamide adenine dinucleotide-dependent deacetylase, Journal of Cell Biology, vol. 158, No. 4, (2002), pp. 647-657.
North Brian J.
Schwer Bjoern
Verdin Eric M.
Borden Paula A.
Bozicevic Field & Francis LLP
Petersen Clark D
The Regents of the University of California
Weber Jon
LandOfFree
Methods of modulating mitochondrial NAD-dependent deacetylase does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of modulating mitochondrial NAD-dependent deacetylase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of modulating mitochondrial NAD-dependent deacetylase will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3795124